跳至主要内容
临床试验/CTRI/2016/04/006872
CTRI/2016/04/006872尚未招募2 期

A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post R0 salvage surgical resection who are ineligible for re-irradiation.

Tata Memorial Hospital0 个研究点目标入组 400 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with recurrenthead and neck cancers with primary in oral cavity, oropharynx, larynx or hypopharynx who have undergone complete salvage resection ( R0 resection)
  • 2.Ineligibile for re-irradiation in target region after assesement in joint clinic.
  • 3.Age >=18 years
  • 4.ECOG performance status PS 0-2
  • 5.Adequate bone marrow function (Haemoglobin > 8 0g/L, platelets > 100 x 109/L, ANC > 1.5 x 109/L)
  • 6.Adequate liver function (ALT/AST < 1.5 x ULN, serum bilirubin < 2mg/dl)
  • 7.Adequate renal function (creatinine clearance > 50 ml/min)
  • 8.Adequate cardiac function (LVEF >40%)
  • 9.Study treatment both planned and able to start within 28 days of enrollment
  • 10.Willing and able to comply with all study requirements, including treatment (able to swallow tablets), able to be followed up at regular intervals and/or nature of required assessments (e.g. able to have IV contrast if this is required for tumour assessments)
  • 11.Signed, written informed consent for main study and tissue banking.

排除标准

  • 1.QTc prolongation (QTc B prolonged more than 450 millisecond)
  • 2.Any significant active infection, including chronic active hepatitis B, hepatitis C, or HIV. for these is not mandatory unless clinically indicated. Participants with known Hepatitis B/C infection will be allowed to participate providing evidence of viral suppression has been documented and the patient remains on appropriate anti-viral therapy.
  • 3.Concurrent illness, including severe infection that may jeopardize the ability of the patient to undergo the procedures outlined in this protocol with reasonable safety; Serious medical (e.g. Diabetes Mellitus, Hypertension, COPD ,active Tuberculosis or psychiatric conditions that might limit the ability of the patient to comply with the protocol.
  • 4.Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule, including alcohol dependence or drug abuse.
  • 5.Pregnancy, lactation, or inadequate contraception. Women must be post menopausal, infertile, or use a reliable means of contraception. Women of childbearing potential must have a negative pregnancy test done within 7 days prior to registration. Men must have been surgically sterilised or use a (double if required) barrier method of contraception.

研究者

相似试验